We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

138 hedge funds and large institutions have $227M invested in DIPLOMAT PHARMACY, INC. in 2019 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 44 increasing their positions, 43 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

379% more call options, than puts

Call options by funds: $2.56M | Put options by funds: $536K

3% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 34

2% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 43

1% more funds holding

Funds holding: 137138 (+1)

28% less capital invested

Capital invested by funds: $317M → $227M (-$90M)

Holders
138
Holders Change
+1
Holders Change %
+0.73%
% of All Funds
2.72%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
35
Increased
44
Reduced
43
Closed
34
Calls
$2.56M
Puts
$536K
Net Calls
+$2.03M
Net Calls Change
-$946K
Name Holding Trade Value Shares
Change
Change in
Stake
SOADOR
76
State of Alaska Department of Revenue
Alaska
$174K -$1.31K -280 -0.6%
AIG
77
American International Group
New York
$169K -$5.22K -1,112 -3%
New York State Teachers Retirement System (NYSTRS)
78
New York State Teachers Retirement System (NYSTRS)
New York
$162K -$470 -100 -0.2%
BAM
79
Blueshift Asset Management
New Jersey
$161K +$34.2K +7,280 +22%
GI
80
GAMCO Investors
Connecticut
$160K +$188K +40,000 New
New York State Common Retirement Fund
81
New York State Common Retirement Fund
New York
$158K -$76.1K -16,200 -29%
TPSF
82
Texas Permanent School Fund
Texas
$158K +$1.26K +269 +0.7%
ASRS
83
Arizona State Retirement System
Arizona
$154K -$137K -29,183 -43%
Squarepoint
84
Squarepoint
New York
$152K -$747K -159,089 -81%
Manulife (Manufacturers Life Insurance)
85
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$148K -$7.08K -1,507 -4%
FIA
86
FNY Investment Advisers
New York
$148K +$174K +37,100 New
FA
87
FCG Advisors
New Jersey
$136K
VOYA Investment Management
88
VOYA Investment Management
Georgia
$124K +$34.6K +7,372 +31%
CM
89
Caption Management
Oklahoma
$120K -$282K -60,000 -67%
Susquehanna International Group
90
Susquehanna International Group
Pennsylvania
$115K -$505K -107,578 -79%
Citigroup
91
Citigroup
New York
$104K -$489K -104,125 -80%
State Board of Administration of Florida Retirement System
92
State Board of Administration of Florida Retirement System
Florida
$99K
AP
93
Advisors Preferred
Maryland
$99K +$116K +24,765 New
AIM
94
Aigen Investment Management
New York
$96K +$113K +24,072 New
Jane Street
95
Jane Street
New York
$95K +$112K +23,823 New
OPERF
96
Oregon Public Employees Retirement Fund
Oregon
$91K
BNP Paribas Financial Markets
97
BNP Paribas Financial Markets
France
$88.6K +$55.2K +11,751 +113%
Citadel Advisors
98
Citadel Advisors
Florida
$82K -$358K -76,293 -79%
CSS
99
Cubist Systematic Strategies
Connecticut
$81K -$18.2K -3,865 -16%
MSA
100
Mason Street Advisors
Wisconsin
$80K +$2.55K +542 +3%

DPLO Hedge Fund Activity: Q4 2019 in Review

138 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q4 2019, worth a combined $227M — down 28% from $317M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new DPLO positions and 34 closed out — a net gain of 1 holder — while 44 added to existing stakes and 43 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $11M. The largest seller was Armistice Capital, exiting entirely with an estimated $26.5M sold.

  • 138 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q4 2019, up from 137 in Q3 2019.
  • Funds reported $227M of DIPLOMAT PHARMACY, INC. stock for Q4 2019, down 28% quarter-over-quarter.
  • 35 funds opened new DIPLOMAT PHARMACY, INC. positions in Q4 2019 and 34 closed out, a net change of +1 holder.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q4 2019 was Renaissance Technologies, an estimated $11M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q4 2019 was Armistice Capital, an estimated $26.5M sold.

Based on aggregated 13F filings for Q4 2019.